A New Beacon of Hope: Bristol Myers Squibb's Breyanzi Achieves Fifth FDA Approval
Texas Attorney General Takes On Pharma Giants Sanofi and Bristol Myers Squibb Over Alleged Plavix Warning Failures
Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress